D-mannose is a rapid inducer of ACSS2 to trigger rapid and long-lasting antidepressant responses through augmenting BDNF and TPH2 levels

Altered mannose metabolism in chronic stress and depression is rapidly reversed by vitamin B12

(2022) Patricia Franzka et al.   Frontiers in Nutrition

BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions

(2022) Susana Cubillos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ketamine and the Future of Rapid-Acting Antidepressants

(2021) Lace M. Riggs et al.   Annual Review of Clinical Psychology

Chronic d-ribose and d-mannose overload induce depressive/anxiety-like behavior and spatial memory impairment in mice

(2021) Ke Xu et al.   Translational Psychiatry

Programmed cell death 4 as an endogenous suppressor of BDNF translation is involved in stress-induced depression

(2020) Yuan Li et al.   MOLECULAR PSYCHIATRY

Decreased tryptophan hydroxylase 2 mRNA and protein expression, decreased brain serotonin concentrations, and anxiety-like behavioral changes in a rat model of simulated transport stress

(2019) Lili Wang et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS

Alcohol metabolism contributes to brain histone acetylation

(2019) P. Mews et al.   NATURE

Lactate in the brain: from metabolic end-product to signalling molecule

(2018) Pierre J. Magistretti et al.   NATURE REVIEWS NEUROSCIENCE

Recent insights into antidepressant therapy: Distinct pathways and potential common mechanisms in the treatment of depressive syndromes

(2018) Dietrich van Calker et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Mannose impairs tumour growth and enhances chemotherapy

(2018) Pablo Sierra Gonzalez et al.   NATURE

Functional characterization of the neuron-restrictive silencer element in the human tryptophan hydroxylase 2 gene expression

(2017) Yukino Nawa et al.   JOURNAL OF NEUROCHEMISTRY

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy

(2017) Xinjian Li et al.   MOLECULAR CELL

Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK

(2017) Chen-Song Zhang et al.   NATURE

Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory

(2017) Philipp Mews et al.   NATURE

D-mannose induces regulatory T cells and suppresses immunopathology

(2017) Dunfang Zhang et al.   NATURE MEDICINE

TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response

(2017) Zhenzhong Ma et al.   Nature Communications

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

(2016) P Zheng et al.   MOLECULAR PSYCHIATRY

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

(2016) Ronald S Duman et al.   NATURE MEDICINE

BDNF – a key transducer of antidepressant effects

(2016) Carl Björkholm et al.   NEUROPHARMACOLOGY

Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures

(2016) Ashley E. Lepack et al.   NEUROPHARMACOLOGY

The Ca 2+ /Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft

(2016) Kathrina L. Marcelo et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Acetyl Coenzyme A: A Central Metabolite and Second Messenger

(2015) Federico Pietrocola et al.   Cell Metabolism

Brain glucose metabolism in an animal model of depression

(2015) J. Detka et al.   NEUROSCIENCE

A simple HPLC assay for plasma D-mannose

(2013) Ichitomo Miwa et al.   CLINICA CHIMICA ACTA

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex

(2013) W. Zhou et al.   EUROPEAN PSYCHIATRY

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

(2013) C. N. Haile et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Advances in tryptophan hydroxylase-2 gene expression regulation: New insights into serotonin-stress interaction and clinical implications

(2012) Guo-Lin Chen et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Epigenetic Modulation of BDNF Gene in Patients with Major Depressive Disorder

(2012) Claudio D'Addario et al.   BIOLOGICAL PSYCHIATRY

Neurotrophin regulation of neural circuit development and function

(2012) Hyungju Park et al.   NATURE REVIEWS NEUROSCIENCE

Treatment-resistant depression: therapeutic trends, challenges, and future directions

(2012) Al-harbi   Patient Preference and Adherence

Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice

(2011) J P R Jacobsen et al.   MOLECULAR PSYCHIATRY

Epigenetic regulation of the BDNF gene: implications for psychiatric disorders

(2011) F Boulle et al.   MOLECULAR PSYCHIATRY

Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice

(2011) Yan Liu et al.   NATURE

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

(2011) Anita E. Autry et al.   NATURE

Targeting tryptophan hydroxylase 2 in affective disorder

(2010) Nina K Popova et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders

(2010) Susann Matthes et al.   PHARMACOLOGY

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

(2009) Oleg Trott et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY

ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

(2009) K. E. Wellen et al.   SCIENCE

Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

(2007) Megan E. Kozisek et al.   PHARMACOLOGY & THERAPEUTICS